The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

Recall of Beztropine Mesylate

by Elizabeth Davis on August 5, 2013 at 10:52 am

Manufacturer Nexus Pharmaceuticals has issued a voluntary recall of two lots of its benztropine mesylate injection. The recall affects the 2 mg / 2 ml, single dose 2 ml vials, and is due to the possibility of visible particulate matter in the vials.

The recall is precautionary; there haven’t been any reported reactions, complaints, or adverse effects at this time.

Nexus is arranging for the return of all affected products, and you can call their customer line at 888-806-4606 with any questions on how to return any unused vials.

The affected lots of benztropine mesylate (030712 and 112911) have the NDC numberĀ 14789-300-02, and expire in 3/2014 and 11/2013.

Check out the FDA Recall page for more information.


Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on GoodRx.com are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.